LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery)

Exclusion Criteria

• •Any contraindication to any of the following medications: aspirin, heparin, clopidogrel, stainless steel, contrast agents, zotarolimus, or everolimus
• •An elective surgical procedure is planned that would necessitate interruption of antiplatelet drugs during the first 6 months post enrollment
• •Acute ST-segment-elevation MI or cardiogenic shock
• •Terminal illness with life expectancy \< 1 year
• •Patients who are actively participating in another drug or device investigational study, which have not completed the primary endpoint follow-up period
• •In-stent restenosis at target vessel (either bare metal stent or drug-eluting stent segment) However, non-target vessel In-stent restenosis is permitted
• •Patients with EF \< 30%
• •Serum creatinine level \>=2.0mg/dL or dependence on dialysis
• •Patients with left main stem stenosis (\> 50% visual estimate)